Vestal Point Capital’s Zai Lab ZLAB Stock Holding History

Vestal Point Capital’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-300,000	Closed	-$7.86M	–	84
2024 Q4	$7.86M	Buy	+300,000	New	+$8.33M	0.47%	47

Other funds holding ZLAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Vestal Point Capital's ZLAB Position: Q1 2025 in Review

Vestal Point Capital sold out of Zai Lab (ZLAB) in Q1 2025, closing a stake of 300,000 shares — an estimated $7.86M sold.

Vestal Point Capital first reported a position in ZLAB in Q4 2024 and held it in 1 quarter. The position peaked at $7.86M in Q4 2024. 160 funds tracked by Wall St. Rank hold ZLAB as of Q1 2025.

Vestal Point Capital reported no remaining Zai Lab position as of Q1 2025 after selling out during the quarter.
Vestal Point Capital sold 300,000 Zai Lab shares in Q1 2025, an estimated $7.86M.
Vestal Point Capital first reported a position in Zai Lab in Q4 2024 and held it in 1 quarter.
Vestal Point Capital's Zai Lab position peaked at $7.86M in Q4 2024.
160 funds tracked by Wall St. Rank held Zai Lab as of Q1 2025.

Based on Vestal Point Capital's 13F filing for Q1 2025, filed 15 May 2025.